Table 1.
Sociodemographic characteristics and comorbidities of patients newly diagnosed with anxiety disorder in April–December 2017–2019 and 2020.
| Incident anxiety disorder in April–December 2017–2019 (n = 63,374) | Incident anxiety disorder in April–December 2020 (n = 25,033) | p-value | Incident depression disorders in April–December 2017–2019 (n = 171,542) | Incident depression disorders in April–December 2020 (n = 57,474) | p-value | Incident reaction to severe stress disorders in April–December 2017–2019 (n = 117.950) | Incident reaction to severe stress disorders in April–December 2020 (n = 39,962) | p-value | |
|---|---|---|---|---|---|---|---|---|---|
| Sociodemographic characteristics | |||||||||
| Age in years, mean (SD) | 51.5 (19.0) | 51.3 (19.1) | <0.001 | 52.8 (18.9) | 53.5 (18.9) | <0.001 | 46.5 (16.8) | 47.5 (17.0) | <0.001 |
| Age 18–25 years | 9.6 | 10.7 | <0.001 | 8.4 | 8.6 | <0.001 | 11.8 | 11.8 | <0.001 |
| Age 26–40 years | 22.8 | 23.3 | 20.9 | 20.7 | 28.2 | 27.0 | |||
| Age 41–60 years | 36.2 | 35.2 | 37.6 | 36.4 | 41.2 | 40.5 | |||
| Age 61–80 years | 23.4 | 22.7 | 24.0 | 24.2 | 15.3 | 16.6 | |||
| Age >80 years | 8.0 | 8.1 | 9.1 | 10.1 | 3.5 | 4.1 | |||
| Sex | |||||||||
| Men | 34.5 | 36.2 | <0.001 | 37.4 | 38.3 | <0.001 | 36.9 | 37.8 | <0.001 |
| Women | 65.5 | 63.8 | 62.6 | 61.7 | 63.1 | 62.2 | |||
| Prescribed Therapies* | |||||||||
| Antidepressants | 19.3 | 16.9 | <0.001 | 26.7 | 25.5 | <0.001 | 8.5 | 8.2 | 0.081 |
| Benzodiazepines | 13.2 | 10.2 | <0.001 | 2.8 | 2.9 | 0.633 | 3.7 | 3.4 | 0.011 |
Data are percentages unless otherwise specified.; SD, standard deviation; *Therapy prescribed on the day of diagnosis of patients newly diagnosed with anxiety disorder, depression, or reaction to severe stress in April–December 2017–2019 and 2020.